$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
Prev. Close
About XTL Biopharmaceuticals Ltd.
Develops therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals
Top Stories
Coming soon.
Develops therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals
Coming soon.